A172 c-edge co-star: risk of reinfection following successful therapy with elbasvir (ebr) and grazoprevir (gzr) in persons who inject drugs (pwid) receiving opiod agonist therapy (oat)

Journal of the Canadian Association of Gastroenterology(2018)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要